On the public citation graph
Pharmacokinetic study of IV infusions of adriamycin
0 signed · 113 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1097-0142(197401)33:1<19::aid-cncr2820330107>3.0.co;2-mopenalex-snapshot
Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule
inferredcites →https://doi.org/10.1002/1097-0142(197704)39:4<1397::aid-cncr2820390407>3.0.co;2-uopenalex-snapshot
Adriamycin cardiomyopathy—risk factors
inferredcites →https://doi.org/10.1002/1097-0142(197808)42:2<399::aid-cncr2820420204>3.0.co;2-5openalex-snapshot
Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology report
inferredcites →https://doi.org/10.1002/1097-0142(19810901)48:5<1088::aid-cncr2820480507>3.0.co;2-wopenalex-snapshot
Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects
inferredcites →https://doi.org/10.1002/1097-0142(19820501)49:9<1762::aid-cncr2820490905>3.0.co;2-qopenalex-snapshot
Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer
inferredcites →https://doi.org/10.1002/1097-0142(19821215)50:12<2731::aid-cncr2820501206>3.0.co;2-popenalex-snapshot
The delivery of cancer chemotherapy by constant venous infusion ambulatory management of venous access and portable pump
inferredcites →https://doi.org/10.1002/cpt1973144part1592openalex-snapshot
Pharmacokinetics and metabolism of adriamycin in man
inferredcites →https://doi.org/10.1007/bf00253003openalex-snapshot
Dose-dependent pharmacokinetics and cancer chemotherapy
inferredcites →https://doi.org/10.1007/bf00265386openalex-snapshot
Plasma levels of doxorubicin after IV bolus injection and infusion of the doxorubicin-DNA complex in rabbits and man
inferredcites →https://doi.org/10.1007/bf00446223openalex-snapshot
Time dependency of adriamycin and adriamycinol kinetics
inferredcites →https://doi.org/10.1007/bf01062831openalex-snapshot
Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data
inferredcites →https://doi.org/10.1007/bf01477050openalex-snapshot
Die Pharmakokinetik von Adriamycin und Adriamycin-Metaboliten
inferredcites →https://doi.org/10.1007/bf02934780openalex-snapshot
Intrahepatic and intravenous administration of adriamycin—A Comparative pharmacokinetic study in patients with malignant liver tumours
inferredcites →https://doi.org/10.1016/0277-5379(82)90072-4openalex-snapshot
Pharmacokinetics of adriamycin in patients with breast cancer: Correlation between pharmacokinetic parameters and clinical short-term response
inferredcites →https://doi.org/10.1016/s0305-7372(76)80018-7openalex-snapshot
Cardiotoxicity of adriamycin and related anthracyclines
inferredcites →https://doi.org/10.1016/s0378-4347(00)81550-9openalex-snapshot
Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol
inferredcites →https://doi.org/10.1038/bjc.1980.165openalex-snapshot
Dependence of the cytostatic effect of adriamycin on drug concentration and exposure time in vitro
inferredcites →https://doi.org/10.1097/00000421-198306000-00017openalex-snapshot
Cancer chemotherapy via ambulatory infusion pump
inferredcites →https://doi.org/10.3329/jom.v12i2.8427openalex-snapshot
A Young Male with Progressive Pallor
inferredcites →https://doi.org/10.7326/0003-4819-91-5-710openalex-snapshot
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
inferredcites →https://doi.org/10.7326/0003-4819-96-2-133openalex-snapshot
Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.892266openalex-extracted
The Geography of Retail Inventory
inferred← citeshttps://doi.org/10.1002/elps.1150191624openalex-snapshot
Therapeutic drug monitoring of doxorubicin in paediatric oncology using capillary electrophoresis
inferred← citeshttps://doi.org/10.1002/mpo.10052openalex-snapshot
Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi‐institutional collaborative study
inferred← citeshttps://doi.org/10.1007/978-1-349-22495-1_14openalex-snapshot
Pharmacokinetic data on antineoplastic and immunosuppressant agents
inferred← citeshttps://doi.org/10.1007/978-1-4615-4811-9_46openalex-snapshot
In Vitro Cytotoxic Drug Activity and In Vivo Pharmacokinetics in Childhood Acute Myeloid Leukemia
inferred← citeshttps://doi.org/10.1007/978-3-642-18156-6_38openalex-snapshot
Drug Monitoring of Doxorubicin in Children
inferred← citeshttps://doi.org/10.1007/bf00262581openalex-snapshot
Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients
inferred← citeshttps://doi.org/10.1007/bf00542426openalex-snapshot
Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration
inferred← citeshttps://doi.org/10.1007/bf00609188openalex-snapshot
Effect of therapeutic concentrations of anthracyclines on monocyte phagocytosis of yeast cells
inferred← citeshttps://doi.org/10.1007/bf00685539openalex-snapshot
Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer
inferred← citeshttps://doi.org/10.1007/bf00685716openalex-snapshot
Doxorubicin and doxorubicinol: intra-and inter-individual variations of pharmacokinetic parameters
inferred← citeshttps://doi.org/10.1007/bf00685876openalex-snapshot
Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit
inferred← citeshttps://doi.org/10.1007/bf00686336openalex-snapshot
Bayesian estimation of doxorubicin pharmacokinetic parameters
inferred← citeshttps://doi.org/10.1007/bf02490784openalex-snapshot
The stability of doxorubicin and ldarubicin in plasma and whole blood
inferred← citeshttps://doi.org/10.1007/bf02934562openalex-snapshot
A pharmacokinetic study of adriamycin and 4′epi-adriamycin after simultaneous intra-arterial liver administration
inferred← citeshttps://doi.org/10.1007/bf02985190openalex-snapshot
Pharmacokinetics of 4′epi-Adriamycin after morning and afternoon intravenous administration
inferred← citeshttps://doi.org/10.1007/bf02989657openalex-snapshot
Epirubicin as a single agent therapy for the treatment of breast cancer — A pharmacokinetic and clinical study
inferred← citeshttps://doi.org/10.1007/s00280-001-0392-4openalex-snapshot
Peak plasma concentrations of doxorubicin in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1007/s00280-004-0900-4openalex-snapshot
Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma
inferred← citeshttps://doi.org/10.1007/s00280-013-2069-1openalex-snapshot
Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years
inferred← citeshttps://doi.org/10.1007/s10495-009-0440-9openalex-snapshot
Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage
inferred← citeshttps://doi.org/10.1007/s10495-010-0564-yopenalex-snapshot
Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage
inferred← citeshttps://doi.org/10.1007/s10549-011-1446-xopenalex-snapshot
A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer
inferred← citeshttps://doi.org/10.1007/s40262-015-0272-4openalex-snapshot
Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer
inferred← citeshttps://doi.org/10.1016/0277-5379(88)90118-6openalex-snapshot
Cytofluorescence localization and disposition of doxorubicin and doxorubicinol in rat cardiac tissue
inferred← citeshttps://doi.org/10.1016/0277-5379(88)90297-0openalex-snapshot
In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells
inferred← citeshttps://doi.org/10.1016/0277-5379(89)90007-2openalex-snapshot
Pharmacokinetics of weekly low dose doxorubicin
inferred← citeshttps://doi.org/10.1016/0277-5379(89)90135-1openalex-snapshot
Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacy
inferred← citeshttps://doi.org/10.1016/0277-5379(90)90255-ropenalex-snapshot
Weekly adriamycin® vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trial
inferred← citeshttps://doi.org/10.1016/0306-9877(89)90161-8openalex-snapshot
Superiority of perfusion over bolus administration in cancer chemotherapy: Proposition of a compartmental model
inferred← citeshttps://doi.org/10.1016/0360-3016(91)90196-bopenalex-snapshot
Efficacy of I.V. or I.P. injected cytotoxic drugs on proliferating and non-proliferating hair follicles of the mouse
inferred← citeshttps://doi.org/10.1016/0378-5173(89)90330-xopenalex-snapshot
Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound anthracycline
inferred← citeshttps://doi.org/10.1016/0959-8049(96)00177-3openalex-snapshot
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: What do we know in the mid-nineties?
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115636openalex-snapshot
A physiologically-based pharmacokinetic model for predicting doxorubicin disposition in multiple tissue levels and quantitative toxicity assessment
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2023.107574openalex-snapshot
A comparative study between conventional chemotherapy and photothermal activated nano-sized targeted drug delivery to solid tumor
inferred← citeshttps://doi.org/10.1016/j.ejca.2003.12.026openalex-snapshot
Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy
inferred← citeshttps://doi.org/10.1016/j.jpba.2018.06.031openalex-snapshot
Optimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studies
inferred← citeshttps://doi.org/10.1016/j.toxlet.2018.05.029openalex-snapshot
Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling
inferred← citeshttps://doi.org/10.1016/s0022-5347(17)32742-8openalex-snapshot
Pharmacokinetics of Intravesical Doxorubicin in Superficial Bladder Cancer Patients
inferred← citeshttps://doi.org/10.1016/s0167-8140(86)80092-5openalex-snapshot
Weekly-dose doxorubicin (WDA) in advanced breast cancer
inferred← citeshttps://doi.org/10.1016/s0378-4347(00)80803-8openalex-snapshot
Rapid quantitative determination of four anthracyclines and their main metabolites in human nucleated haematopoietic cells
inferred← citeshttps://doi.org/10.1016/s0959-8049(97)10055-7openalex-snapshot
Bolus injection (2–4min) versus short-term (10–20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.6b00886openalex-snapshot
In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.7b00840openalex-snapshot
Reply to “Comment on ‘In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma’”
inferred← citeshttps://doi.org/10.1021/acs.nanolett.9b01202openalex-snapshot
Quantitative Drug Release Monitoring in Tumors of Living Subjects by Magnetic Particle Imaging Nanocomposite
inferred← citeshttps://doi.org/10.1021/pr1007043openalex-snapshot
Quantitative Proteomic Analysis Reveals the Perturbation of Multiple Cellular Pathways in Jurkat-T Cells Induced by Doxorubicin
inferred← citeshttps://doi.org/10.1023/a:1008334913109openalex-snapshot
Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: A prospective randomised trial
inferred← citeshttps://doi.org/10.1038/bjc.1995.27openalex-snapshot
Pharmacokinetics of doxorubicin co-administered with high-dose verapamil
inferred← citeshttps://doi.org/10.1038/s41551-017-0070openalex-snapshot
Closed-loop control of circulating drug levels in live animals
inferred← citeshttps://doi.org/10.1051/mmnp:2008003openalex-snapshot
Improving Cancer Therapy by Doxorubicin and Granulocyte Colony-Stimulating Factor: Insights from a Computerized Model of Human Granulopoiesis
inferred← citeshttps://doi.org/10.1080/08880010701451343openalex-snapshot
PHARMACOKINETICS OF DOXORUBICIN AND ETOPOSIDE IN A MORBIDLY OBESE PEDIATRIC PATIENT
inferred← citeshttps://doi.org/10.1089/cdd.1987.4.191openalex-snapshot
Continuous Infusion or Intravenous Bolus: What Is the Rationale for Doxorubicin Administration?
inferred← citeshttps://doi.org/10.1089/sct.1991.7.159openalex-snapshot
A Model for Mimicking the Pharmacokinetics of Chemotherapy Drugs for Evaluation of Drug Effects in a Soft Agar Colony Formation Assay System
inferred← citeshttps://doi.org/10.1097/00001813-200002000-00010openalex-snapshot
A comparative pharmacokinetic study of doxorubicin and 4′-epi-doxorubicin in children with acute lymphocytic leukemia using a limited sampling procedure
inferred← citeshttps://doi.org/10.1097/00001813-200111000-00011openalex-snapshot
Quantification of doxorubicin in plasma—a comparative study of capillary and venous blood sampling
inferred← citeshttps://doi.org/10.1097/00008571-200007000-00001openalex-snapshot
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.
inferred← citeshttps://doi.org/10.1097/01.cad.0000198911.98442.16openalex-snapshot
Doxorubicin pharmacokinetics is correlated to the effect of induction therapy in children with acute myeloid leukemia
inferred← citeshttps://doi.org/10.1097/01.ftd.0000158867.66994.91openalex-snapshot
Association Between Alopecia and Response to Chemotherapy in Patients With Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1097/fpc.0b013e328301a869openalex-snapshot
Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity
inferred← citeshttps://doi.org/10.1097/ftd.0b013e3181c3a16dopenalex-snapshot
Doxorubicin in Lymphoma: Association Between Pharmacokinetic Variability and Clinical Response
inferred← citeshttps://doi.org/10.1097/ftd.0b013e31825a4d9copenalex-snapshot
Minimization of the Preanalytical Error in Pharmacokinetic Analyses and Therapeutic Drug Monitoring
inferred← citeshttps://doi.org/10.1101/2023.03.28.534654openalex-snapshot
SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species
inferred← citeshttps://doi.org/10.1111/ajco.13776openalex-snapshot
Population pharmacokinetics of doxorubicin: A systematic review
inferred← citeshttps://doi.org/10.1140/epjnbp/s40366-014-0013-xopenalex-snapshot
A multi-compartment pharmacokinetic model of the interaction between paclitaxel and doxorubicin
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-04-1969openalex-snapshot
Intraprostatic Chemotherapy: Distribution and Transport Mechanisms
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-06-1610openalex-snapshot
Computational Modeling to Predict Effect of Treatment Schedule on Drug Delivery to Prostate in Humans
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-06-2776openalex-snapshot
Phase I and Pharmacokinetic Study of the (6-Maleimidocaproyl)Hydrazone Derivative of Doxorubicin
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-24-2539openalex-snapshot
Development of a First-in-Class Click Chemistry–Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial
inferred← citeshttps://doi.org/10.1159/000057665openalex-snapshot
Bactericidal Effect of Combinations of Antibiotic and Antineoplastic Agents against Staphylococcus aureus and Escherichia coli
inferred← citeshttps://doi.org/10.11606/d.60.2017.tde-12122016-160641openalex-snapshot
Farmacocinética, metabolismo e excreção renal da doxorrubicina em pacientes com câncer de mama
inferred← citeshttps://doi.org/10.1177/1078155220985919openalex-snapshot
Evaluating the incidence of chemotherapy-induced nausea and vomiting in patients with B-cell lymphoma receiving dose-adjusted EPOCH and rituximab
inferred← citeshttps://doi.org/10.1186/1742-4682-6-16openalex-snapshot
A tumor cord model for Doxorubicin delivery and dose optimization in solid tumors
inferred← citeshttps://doi.org/10.1186/s40360-020-00417-2openalex-snapshot
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
inferred← citeshttps://doi.org/10.1200/jco.1988.6.3.517openalex-snapshot
Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans.
inferred← citeshttps://doi.org/10.13005/bpj/2468openalex-snapshot
Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment
inferred← citeshttps://doi.org/10.1517/13543784.16.6.855openalex-snapshot
DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials
inferred← citeshttps://doi.org/10.2165/00003088-198815010-00002openalex-snapshot
Clinical Pharmacokinetics of Doxorubicin
inferred← citeshttps://doi.org/10.26481/dis.20190517mvopenalex-snapshot
Transcriptomics close to my heart
inferred← citeshttps://doi.org/10.3109/02841868909092323openalex-snapshot
Pharmacokinetics of Anthracyclines
inferred← citeshttps://doi.org/10.3109/02841869009090011openalex-snapshot
Anthracycline Pharmacokinetics: Limited sampling model for plasma level monitoring with special reference to epirubicin (Farmorubicin)
inferred← citeshttps://doi.org/10.3109/02841869009096390openalex-snapshot
Plasma Pharmacokinetics of Idarubicin and its 13-Hydroxymetabolite after Intravenous and Oral Administration under Fasting and Non-Fasting Conditions
inferred← citeshttps://doi.org/10.3109/02841869509094021openalex-snapshot
Accidental Doxorubicin Overdosage
inferred← citeshttps://doi.org/10.3109/10428199209053588openalex-snapshot
Pharmacokinetics of Mitoxantrone in Plasma and Leukemic Cells During Treatment of Patients with Acute Non-Lymphocytic Leukemia
inferred← citeshttps://doi.org/10.3389/fphar.2026.1924670openalex-snapshot
microRNA-15b modulates stress-induced premature senescence in chronic doxorubicin cardiomyopathy
inferred← citeshttps://doi.org/10.6084/m9.figshare.12386198openalex-snapshot
Additional file 1 of Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
inferred← citeshttps://doi.org/10.6084/m9.figshare.12386207openalex-snapshot
Additional file 2 of Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
inferred← citeshttps://doi.org/10.6084/m9.figshare.12386213openalex-snapshot
Additional file 3 of Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
inferred← citeshttps://doi.org/10.6084/m9.figshare.12386222openalex-snapshot
Additional file 4 of Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure
inferred← citeshttps://doi.org/10.70675/e62d69b6z1f00z4f88z817bzda54e624150fopenalex-snapshot
Les cellules sénecentes comme niche de survie : rôle de la voie TSP1-CD47
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.